The slip
PARKINSON RECEIPTno. 12741
28 Oct 2026, 06:18 UTCdopamine neurons, braak
predictionRFX4 in dopamine neurons tracks Braak Lewy-body stage
registered76737a82aa8a9142
discovery+0.38 p=0.311 n=9
replication-0.13 p=0.741 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.38, p 0.311)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT34622b11d503c1b77216a5ee…
follows 3ff9040b8e64…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12741: RFX4 in dopamine neurons, braak
- power
- full sample +0.26 (p 0.302, n 18), 95% CI -0.24 to +0.65. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.24 (p 0.332, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.26 (p 0.302, n 18). could be the mix.
- skeptic
- leave-one-out range +0.17 to +0.40, sign flips 0; without severely affected donors +0.26 (p 0.302, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RFX4 in dopamine neurons.
case closed: nothing better to follow up.